News

Molecular testing in dermatology involves decisions about who gets tested, how to test and interpret results, and where to go ...
Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of ...
Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of ...
Novartis hopes of bringing Cosentyx to patients with giant cell arteritis seem to be over after the drug missed all the endpoints in a phase 3 trial.